Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ProPhase Labs (PRPH) EPS (Weighted Average and Diluted): 2011-2024

Historic EPS (Weighted Average and Diluted) for ProPhase Labs (PRPH) over the last 13 years, with Dec 2024 value amounting to -$2.61.

  • ProPhase Labs' EPS (Weighted Average and Diluted) rose 54.29% to -$0.16 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.99, marking a year-over-year decrease of 28.39%. This contributed to the annual value of -$2.61 for FY2024, which is 166.33% down from last year.
  • ProPhase Labs' EPS (Weighted Average and Diluted) amounted to -$2.61 in FY2024, which was down 166.33% from -$0.98 recorded in FY2023.
  • Over the past 5 years, ProPhase Labs' EPS (Weighted Average and Diluted) peaked at $1.02 during FY2022, and registered a low of -$2.61 during FY2024.
  • In the last 3 years, ProPhase Labs' EPS (Weighted Average and Diluted) had a median value of -$0.98 in 2023 and averaged -$0.86.
  • Per our database at Business Quant, ProPhase Labs' EPS (Weighted Average and Diluted) soared by 300.00% in 2021 and then tumbled by 196.08% in 2023.
  • Yearly analysis of 5 years shows ProPhase Labs' EPS (Weighted Average and Diluted) stood at -$0.20 in 2020, then soared by 300.00% to $0.40 in 2021, then soared by 155.00% to $1.02 in 2022, then slumped by 196.08% to -$0.98 in 2023, then tumbled by 166.33% to -$2.61 in 2024.